Standpoint Research Starts Citi (C) at Buy, $55 Price Target
Tweet Send to a Friend
Get Alerts C Hot Sheet
Price: $49.81 -0.4%
Rating Summary:
18 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Rating Summary:
18 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Trade C Now!
Standpoint Research initiated coverage on shares of Citi (NYSE: C) with a Buy rating and a $55 price target Tuesday afternoon.
The firm said, "During the last 90 days, financials have underperformed the S&P by 1000 bps and Citigroup has underperformed by 1500 bps. We think this is a good time to reduce our bet against this industry while taking a longer term view than we normally do."
Standpoint said it has maintained an Underweight sector rating on banks since 2007.
The firm warned Citi shares are "levered to the fragile economy and not recommended for those who are overweight banks."
With Citi shares up 1.9 percent to $38.88 this afternoon, Standpoint's new price target implies potential upside of about 41 percent.
For more ratings news on Citi click here and for the rating history of Citi click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm said, "During the last 90 days, financials have underperformed the S&P by 1000 bps and Citigroup has underperformed by 1500 bps. We think this is a good time to reduce our bet against this industry while taking a longer term view than we normally do."
Standpoint said it has maintained an Underweight sector rating on banks since 2007.
The firm warned Citi shares are "levered to the fragile economy and not recommended for those who are overweight banks."
With Citi shares up 1.9 percent to $38.88 this afternoon, Standpoint's new price target implies potential upside of about 41 percent.
For more ratings news on Citi click here and for the rating history of Citi click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Citigroup Announces Expiration and Final Tender Results of Offers to Purchase Four Series of Outstanding Notes
- UPDATE: Citi Raises PT on Micron Technology (MU) to $19
Create E-mail Alert Related Categories
New CoverageRelated Entities
Citi, Standard & Poor's, Standpoint Research
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
